Ocular Therapeutix (OCUL) Depreciation and Depletion (2013 - 2014)
Ocular Therapeutix's (OCUL) quarterly Depreciation and Depletion came in at $139000.0 in Q3 2014, up 51.09% year-on-year from $92000.0 in Q3 2013, and up 51.09% quarter-over-quarter from $92000.0 in Q3 2013.
Ocular Therapeutix (OCUL) Depreciation and Depletion (2013 - 2014) Analysis & Trends
Ocular Therapeutix's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $139000.0 for Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Ocular Therapeutix | 1.93 Bn | 1.93 Bn | 9.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 139,000.00 |
| Sep 30, 2014 | 139,000.00 |
| Sep 30, 2013 | 92,000.00 |
| Sep 30, 2013 | 92,000.00 |